Home Overview Press Room Blog Publications For Students about us

Personal genomics : Displaying 21-40 of 780

Ancestry.com is talking to the FDA about using DNA to estimate people's risk of diseaseby Arielle Duhaime-RossThe VergeOctober 12th, 2015After the FDA regulated 23andMe, another big player in the personal genomics business who has focused on genetic ancestry is looking to merge into providing lucrative health information.
Video Review: Talking Biopolitics[cites CGS and CGS fellow Lisa Ikemoto]by Rebecca DimondBioNewsOctober 12th, 2015George Annas spoke with Lisa Ikemoto about his new book on genomic medicine and genetic testing.
Genes can’t be patented, rules Australia’s High Courtby Michael SlezakNew ScientistOctober 7th, 2015The decision is considered stronger than the similar one by the US Supreme Court.
UNESCO Calls for More Regulations on Genome Editing, DTC Genetic Testingby StaffGenomeWebOctober 6th, 2015The organization's International Bioethics Committee reaffirms its support for a moratorium on modifying the human germline.
New Psychiatric DNA Testing Is Unproven Groundby Susan Donaldson JamesNBC NewsOctober 4th, 2015Using genetic testing to determine the best course of psychiatric medications is an unproven proposition that may pose risks to patients' health.
Who has your DNA—or wants itby Jocelyn KaiserScienceSeptember 25th, 2015More and more groups are amassing computer server–busting amounts of human DNA. At least 17 biobanks that hold, or plan to hold, genomic data on 75,000 or more people.
Can 23andMe have it all?by Kelly ServickScienceSeptember 25th, 2015The company has made about 30 deals with biotech and pharma companies, and plans to hire 25 scientists in the next year to begin drug discovery efforts of its own.
Can knowing you and your family may get Alzheimer’s ever be positive?by Giulia RhodesThe GuardianSeptember 21st, 2015In the vast majority of cases, the cause of Alzheimer’s remains unclear, a complex interplay of environmental and genetic factors not yet fully understood.
Blueprint in hand, NIH embarks on study of a million peopleby Jocelyn KaiserScience InsiderSeptember 17th, 2015As the Precision Medicine Initiative million-person study moves forward, an NIH committee is urging the recruitment of any willing volunteers.
Why you shouldn’t know too much about your own genesby Carolyn JohnsonWashington PostSeptember 11th, 2015The poster child for the uncertainty underlying direct-to-consumer DNA testing is a gene called MTHFR. In almost no cases does testing for it have any medical utility.
Genetic testing firms in China happy to sell your DNA secretsby Staff ReporterWant China TimesSeptember 10th, 2015As 23andMe strikes a slew of pharma and biotech deals, it's an open secret that sequencing companies can't make money on tests, but rely on the value of big bio data to drug developers.
"Moonshot Medicine": Putative Precision vs. Messy Genomesby Gina Maranto, Biopolitical Times guest contributorSeptember 9th, 2015The promise is "personalized" genetic treatment plans; the reality is that most health disparities are environmental.
Biotech Imagination: Whose Future is this?by Jessica CussinsSeptember 8th, 2015A feature in PLOS Biology highlights insider predictions about the next ten years in genetics and genomics with unanimous optimism. But whose future is this?
Personal Responsibilityby EditorialNatureSeptember 1st, 2015The US Precision Medicine Initiative needs to tread carefully when revealing health and genetic data to participants.
Giant study poses DNA data-sharing dilemmaby Sara ReardonNature NewsSeptember 1st, 2015As the US Precision Medicine Initiative pushes forward, whether to provide sequenced genetic information to biobank donors is an unresolved question of ethics, privacy, and medical utility.
Debate Ensues as Prenatal Tests Reach Beyond Down Syndromeby Antonio RegaladoMIT Technology ReviewAugust 31st, 2015Doctors and genetic counselors question the expanding scope of blood tests during pregnancy.
The Risks of Turning Races Into Genes by Matthew W. HugheyThe Huffington PostAugust 20th, 2015"Race" is man-made, and much of the scientific enterprise has traditionally supported the myth that racial differences accurately represent real, biological differences among humans.
Inside Illumina’s Plans to Lure Consumers with an App Store for Genomes by Antonio RegaladoMIT Technology ReviewAugust 19th, 2015The head of the largest gene-sequencing company envisions holding your DNA, then selling it to you little by little.
B.C. Company to Launch DNA Testing Service by Pamela FayermanVancouver SunAugust 19th, 2015British Columbia is grappling with regulatory and accreditation issues for a company planning to launch the first direct-to-consumer DNA testing service based in the province.
We Might Not Want to Know the Dark Secrets Lurking in Our Genesby Kevin LoriaTech InsiderAugust 17th, 2015Once we're good enough at reading a DNA sequence to really interpret all the results — rather than just glean a few hints here and there — we may not want to know the answers.
Displaying 21-40 of 780  
< Prev  Next >> 
« First Page Last Page » 
« Show Complete List » 


home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1936 University Ave, Suite 350, Berkeley, CA 94704 • • (p) 1.510.665.7760 • (F) 1.510.665.8760